...b), and large plasmid insert (10-20kb) DNAs. Great...ommand 20-50 fold copy amplification for high yiel...e with blue-white screening (pEZ BAC) or transcrip...rt stability. Kits include electrocompetent cells ...
6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein, succinimidyl ester (6-HEX, SE) *single isomer* from Molecular Probes (Invitrogen)
Mouse Anti-TGF-beta 2 Monoclonal Antibody, Unconjugated, Clone 8607 from R&D Systems
DNP-X acid, SE -- [6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester] from AnaSpec
Biology Products:CopyRight pSMART VC Blunt Cloning Kit (without cells) from Lucigen6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein, succinimidyl ester (6-HEX, SE) *single isomer* from Molecular Probes (Invitrogen)Mouse Anti-TGF-beta 2 Monoclonal Antibody, Unconjugated, Clone 8607 from R&D SystemsDNP-X acid, SE -- [6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester] from AnaSpec ...DNA have different structures that are treated dif...l Center researchers have found in a study that co...ublished in the Feb. 3 issue of the journal Molecu...pped by segments called telomeres. Each time the c...me too short, the aging cell can no longer divide....
...emonstrates that honey, one of the oldest healing ...ults when used as a wound dressing. A review artic...International Journal of Lower Extremity Wounds su...s involving 2,062 patients treated with honey, as ...d on experimental animals. Honey was found to be b...
... donor stem cells given to animals that have neuro...ts with a stroke or newborns with cerebral palsy c... of injuries, researchers say. , Using a commonly ...nistered a dose of 200,000-400,000 human stem cell...ignificant loss of mobility and other functions. ...
Other Biology News:DNA end caps may lead to cancer treatments, UT Southwestern researchers report 2Stem cell transplants improve recovery in animal models for stroke, cerebral palsy 2Stem cell transplants improve recovery in animal models for stroke, cerebral palsy 3Stem cell transplants improve recovery in animal models for stroke, cerebral palsy 4Stem cell transplants improve recovery in animal models for stroke, cerebral palsy 5(Date:11/19/2009)...ov. 19 Omeros Corporatio...cial results for the third quarter ended September..., 2009, Omeros reported a net loss of $3.9 million... $7.4 million, or $2.54 per share, for the same pe...30, 2009, the Company reported a net loss of $15.5...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 ...or in biotechnology for diabetes therapy, and a pr...ices to food, supplement, biotechnology and pharma...previously reported $6.3 million registered direct... shares of its common stock and warrants to purcha...
(Date:11/19/2009)...Md., Nov. 19 Spherix Inc...hnology for diabetes therapy, and a provider of te..., supplement, biotechnology and pharmaceutical com...nnual Meeting of Shareholders. ,, At the meetin...SPEX ) elected the following members to the Board ...
(Date:11/19/2009)...STER, Germany, November 19 MONITOR...ovember 16th, 2009 Flibanserin in the,indication t...arkinson,s,disease for orphan drug status designat...odopa-induced dyskinesia is a complication of the ...erious burden to some of those,affected, since it ...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2